Kenneth d'Entremont

All filings by Kenneth d'Entremont on record concern Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The record holds 37 filings, for trades running from 27 August 2019 to 28 June 2024.

On the open market, the record shows 30 purchases worth €190k and 1 sale worth €1,603. On balance, insiders were net buyers of €189k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 option exercises. In 2024 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €4,808. The 30 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 28 June 2024 came the latest disclosure, an open-market purchase for €1,193 in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.